Newsletter
Sign up for the Fund's newsletter and get the lastest news, calls and events
| Titel Sort descending | Periode | Program | |
|---|---|---|---|
| Nordiq Group NG-Plan | 2020 - 2021 | Innobooster
|
|
|
Nordiq Group NG-Plan
Period
2020 - 2021
Region
Region Hovedstaden Program
Innobooster Area
Ikke defineret Investment
Percentage
30.8 Invested
472.841 Budget
1.5 mill. Partners
Nordiq Group A/S People
Nordiq Group A/S
Read more about the project
| |||
| Nordiqo Monitor – udvikling af ny digital bank- og rådgivnings app og platform | 2021 - 2022 | Innobooster
|
|
|
Nordiqo Monitor – udvikling af ny digital bank- og rådgivnings app og platform
Period
2021 - 2022
Region
Region Midtjylland Program
Innobooster Area
Ikke defineret Investment
Percentage
33 Invested
797.775 Budget
2.4 mill. Partners
Nordiqo ApS People
Nordiqo ApS
Read more about the project
| |||
| Nordisk Element Byg AS | 2016 - 2018 | Innobooster
|
|
|
Nordisk Element Byg AS
Period
2016 - 2018
Region
Region Nordjylland Program
Innobooster Area
Ikke defineret Investment
Percentage
100 Invested
300.000 Budget
300.000 Partners
NORDISK ELEMENT BYG A/S People
NORDISK ELEMENT BYG A/S
Read more about the project
| |||
| Nordisk shelter projekt | 2016 - 2017 | Innobooster
|
|
|
Nordisk shelter projekt
Period
2016 - 2017
Region
Region Midtjylland Program
Innobooster Area
Ikke defineret Investment
Percentage
32.98 Invested
470.000 Budget
1.4 mill. Partners
NORDISK COMPANY A/S People
NORDISK COMPANY A/S
Read more about the project
| |||
| Nordiske plante-tapas | 2020 - 2021 | Innobooster
|
|
|
Nordiske plante-tapas
Period
2020 - 2021
Region
Region Hovedstaden Program
Innobooster Area
Ikke defineret Investment
Percentage
33 Invested
163.350 Budget
495.000 Partners
FANGST People
Fangst Foods ApS
Read more about the project
| |||
| Nordium - Søg efter akuttider på tværs af relevante behandlere | 2022 - 2022 | Innobooster
|
|
|
Nordium - Søg efter akuttider på tværs af relevante behandlere
Period
2022 - 2022
Region
Region Nordjylland Program
Innobooster Area
Ikke defineret Investment
Percentage
35 Invested
258.475 Budget
738.500 Partners
Nordium I/S People
Nordium I/S
Read more about the project
| |||
| Nordivir | 2017 - 2018 | Innobooster
|
|
|
Nordivir
Period
2017 - 2018
Region
Region Hovedstaden Program
Innobooster Area
Ikke defineret Investment
Percentage
33 Invested
209.220 Budget
634.000 Partners
Fjord Pharmaceuticals IVS People
Fjord Pharmaceuticals IVS
Read more about the project
| |||
| Nordstar Medical | 2024 - 2025 | Innobooster
|
|
|
Nordstar Medical
Period
2024 - 2025
Region
Program
Innobooster Area
Ikke defineret Investment
Percentage
35 Invested
1.4 mill. Budget
4.0 mill. Partners
NordStar Medical ApS People
NordStar Medical ApS
Read more about the project
| |||
| NORFAB: Protein til den nordlige halvkugle | 2016 - 2021 | Grand Solutions
|
|
|
NORFAB: Protein til den nordlige halvkugle
Period
2016 - 2021
Region
Region Midtjylland Program
Grand Solutions Area
Bioressourcer, Fødevarer og Livsstil Investment
Percentage
59.36 Invested
27.5 mill. Budget
46.4 mill. Partners
Aarhus University, Aarhus University, University of Copenhagen, Sejet Planteforædling I/S, Nordic Seed A/S, Dansk Landbrugs Grovvareselskab A.M.B.A, University of Saskatchewan, University of Reading, University of Helsinki, 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 26, 27, 28, 29, 30, 31, 32, 33, 34, 35, 36, 37, 38, 39, 40, 41, 42, 43, 44, 45, 46, 47, 48, 49, 50, 51 People
Aarhus Universitet
Read more about the project
| |||
| NorFalk | 2022 - 2023 | Innofounder
|
|
|
NorFalk
Period
2022 - 2023
Region
Region Midtjylland Program
Innofounder Area
Ikke defineret Investment
Percentage
100 Invested
760.000 Budget
760.000 Partners
NorFalk ApS People
NorFalk ApS
Read more about the project
| |||
| Norly & Friends | 2020 - 2021 | Innobooster
|
|
|
Norly & Friends
Period
2020 - 2021
Region
Region Nordjylland Program
Innobooster Area
Ikke defineret Investment
Percentage
32.16 Invested
404.052 Budget
1.3 mill. Partners
Norly and Friends ApS People
TUK ApS
Read more about the project
| |||
| North: a smart carbon accounting software solution for organizations. | 2020 - 2021 | Innobooster
|
|
|
North: a smart carbon accounting software solution for organizations.
Period
2020 - 2021
Region
Region Hovedstaden Program
Innobooster Area
Ikke defineret Investment
Percentage
30.36 Invested
421.195 Budget
1.4 mill. Partners
Tmrow ApS People
TMROW ApS
Read more about the project
| |||
| NorthArc ApS Innofounder Ansøgning | 2020 - 2021 | Innofounder
|
|
|
NorthArc ApS Innofounder Ansøgning
Period
2020 - 2021
Region
Region Hovedstaden Program
Innofounder Area
Produktion, Materialer, Digitalisering og IKT Investment
Percentage
100 Invested
460.000 Budget
460.000 Partners
NorthArc ApS People
NorthArc ApS
Read more about the project
| |||
| Nosco - making innovation everybody's business | 2020 - 2021 | Innobooster
|
|
|
Nosco - making innovation everybody's business
Period
2020 - 2021
Region
Region Hovedstaden Program
Innobooster Area
Ikke defineret Investment
Percentage
32.71 Invested
541.728 Budget
1.7 mill. Partners
Nosco ApS People
NOSCO ApS
Read more about the project
| |||
| NOTIFY NTY001 a hormone-free treatment for female infertility: Effects on Nonhuman Primate Female Rhesus Macaque Follicle Development and Oocyte Fertilization | 2023 - 2025 | Grand Solutions
|
|
|
NOTIFY NTY001 a hormone-free treatment for female infertility: Effects on Nonhuman Primate Female Rhesus Macaque Follicle Development and Oocyte Fertilization
Period
2023 - 2025
Region
Program
Grand Solutions Area
Ikke defineret Investment
Percentage
42.8 Invested
5.9 mill. Budget
13.8 mill. While assisted reproductive technologies have allowed millions of couples to have children, their success rates have not increased dramatically. Treatment of infertility related to ovarian function have not developed over the last past 25 years. This project ties directly into increased agency and health of women as it increases the possibility for family planning.
We have identified a drug, NTY001, which can help to mature egg, independent of hormones. This has a major impact on women not benefitting from the hormone treatment given today, or do not tolerate the treatment, due to disease and/or age. We have shown proof of concept of efficacy in aged female mice, where NTY001 treatment successfully made the female mice pregnant and resulted in life birth. We are now in the progress of providing additional proof of concept in aged non-human primates, as a translational model for mono-ovulatory species, like human. We will monitor egg formation, fertilisation rates and embryo development in the primates treated with NTY001. Further to this, we will generate an endocrine profile, measuring hormones before and after treatment, to evaluate the safety, as well, in the non-human primates. We wish to take this invention et step closer to the bed side, and with the non-human primate results, we expect to enter the clinical phase 1a ultimo 2023.
Partners
iNotify ApS People
Read more about the project
| |||